These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27619738

  • 41. Morphological and physiological study of the cardiac NOS/NO system in the Antarctic (Hb-/Mb-) icefish Chaenocephalus aceratus and in the red-blooded Trematomus bernacchii.
    Garofalo F, Amelio D, Cerra MC, Tota B, Sidell BD, Pellegrino D.
    Nitric Oxide; 2009 Mar; 20(2):69-78. PubMed ID: 19027084
    [Abstract] [Full Text] [Related]

  • 42. Chelation of hypocrellin B with zinc ions with electron paramagnetic resonance (EPR) evidence of the photodynamic activity of the resulting chelate.
    Tian C, Xu S, Chen S, Shen J, Zhang M, Shen T.
    Free Radic Res; 2001 Nov; 35(5):543-54. PubMed ID: 11767412
    [Abstract] [Full Text] [Related]

  • 43. Perylenequinones in photodynamic therapy: cellular versus vascular response.
    Olivo M, Chin W.
    J Environ Pathol Toxicol Oncol; 2006 Nov; 25(1-2):223-37. PubMed ID: 16566720
    [Abstract] [Full Text] [Related]

  • 44. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity.
    Deng H, Liu X, Xie J, Yin R, Huang N, Gu Y, Zhao J.
    J Med Chem; 2012 Mar 08; 55(5):1910-9. PubMed ID: 22352922
    [Abstract] [Full Text] [Related]

  • 45. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
    Girotti AW, Fahey JM, Korytowski W.
    Curr Med Chem; 2016 Mar 08; 23(24):2754-2769. PubMed ID: 27776475
    [Abstract] [Full Text] [Related]

  • 46. The efficacy of Radachlorin-mediated photodynamic therapy in human hepatocellular carcinoma cells.
    Mirzaei H, Djavid GE, Hadizadeh M, Jahanshiri-Moghadam M, Hajian P.
    J Photochem Photobiol B; 2015 Jan 08; 142():86-91. PubMed ID: 25528192
    [Abstract] [Full Text] [Related]

  • 47. Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
    Xu S, Chen S, Zhang M, Shen T, Liu Z, Zhao Y, Wu Y.
    Anticancer Drug Des; 2001 Dec 08; 16(6):271-7. PubMed ID: 12375880
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Hypocrellin B in hepatocellular carcinoma cells: Subcellular localization and sonodynamic damage.
    Wang X, Luo J, Leung AW, Li Y, Zhang H, Xu C.
    Int J Radiat Biol; 2015 May 08; 91(5):399-406. PubMed ID: 25565557
    [Abstract] [Full Text] [Related]

  • 50. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
    Fahey JM, Stancill JS, Smith BC, Girotti AW.
    J Biol Chem; 2018 Apr 06; 293(14):5345-5359. PubMed ID: 29440272
    [Abstract] [Full Text] [Related]

  • 51. Photocytotoxicity of hypocrellin B (HB) was enhanced by liposomalization in vitro.
    Zhou Z, Zhang L, Liu H, Zhang Q, Liu B, Ai P, Ma H, Liu W, Li Z, Sheng W, Zeng Y, Zhong R.
    Int J Toxicol; 2011 Mar 06; 30(2):174-80. PubMed ID: 21536921
    [Abstract] [Full Text] [Related]

  • 52. Photodynamic inhibitory effects of three perylenequinones on human colorectal carcinoma cell line and primate embryonic stem cell line.
    Ma L, Tai H, Li C, Zhang Y, Wang ZH, Ji WZ.
    World J Gastroenterol; 2003 Mar 06; 9(3):485-90. PubMed ID: 12632502
    [Abstract] [Full Text] [Related]

  • 53. N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide.
    Rakshit S, Bagchi J, Mandal L, Paul K, Ganguly D, Bhattacharjee S, Ghosh M, Biswas N, Chaudhuri U, Bandyopadhyay S.
    Apoptosis; 2009 Mar 06; 14(3):298-308. PubMed ID: 19153832
    [Abstract] [Full Text] [Related]

  • 54. Enhancement of oxaliplatin sensitivity in human colorectal cancer by hypericin mediated photodynamic therapy via ROS-related mechanism.
    Lin S, Lei K, Du W, Yang L, Shi H, Gao Y, Yin P, Liang X, Liu J.
    Int J Biochem Cell Biol; 2016 Feb 06; 71():24-34. PubMed ID: 26673998
    [Abstract] [Full Text] [Related]

  • 55. Effect of structural modifications on photosensitizing activities of hypocrellin dyes: EPR and spectrophotometric studies.
    Yuying H, Jingyi A, Lijin J.
    Free Radic Biol Med; 1999 May 06; 26(9-10):1146-57. PubMed ID: 10381185
    [Abstract] [Full Text] [Related]

  • 56. Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.
    Babu A, Jeyasubramanian K, Gunasekaran P, Murugesan R.
    J Biomed Nanotechnol; 2012 Feb 06; 8(1):43-56. PubMed ID: 22515093
    [Abstract] [Full Text] [Related]

  • 57. Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model.
    Bhowmick R, Girotti AW.
    Cancer Lett; 2014 Feb 01; 343(1):115-22. PubMed ID: 24080338
    [Abstract] [Full Text] [Related]

  • 58. Effects of photodynamic therapy using Red LED-light combined with hypocrellin B on apoptotic signaling in cutaneous squamous cell carcinoma A431 cells.
    Liu Y, Cao Z, Wei G.
    Photodiagnosis Photodyn Ther; 2023 Sep 01; 43():103683. PubMed ID: 37390854
    [Abstract] [Full Text] [Related]

  • 59. Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H2O2-expressing cancer cells.
    Kitamura T, Nakata H, Takahashi D, Toshima K.
    Chem Commun (Camb); 2021 Dec 23; 58(2):242-245. PubMed ID: 34850796
    [Abstract] [Full Text] [Related]

  • 60. Efficacy of hypocrellin pharmacokinetics in phototherapy.
    Ali SM, Olivo M.
    Int J Oncol; 2002 Dec 23; 21(6):1229-37. PubMed ID: 12429972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.